MTB-NTM Multiplex Real-Time PCR Kit
Example report highlights MTB-positive, NTM-positive, or negative results, along with amplification curves for each target and internal control validation.
Accurate differentiation between Mycobacterium tuberculosis (MTB) and Non-Tuberculous Mycobacteria (NTM) — enabling precise diagnosis and appropriate treatment decisions.
The MTB-NTM Multiplex Real-Time PCR Kit is an advanced in vitro diagnostic assay developed for the qualitative differentiation of Mycobacterium tuberculosis (MTB) and Non-Tuberculous Mycobacteria (NTM). directly from clinical specimens. By targeting unique genetic markers of both pathogen types, this assay provides. rapid, reliable, and actionable results, reducing misdiagnosis and improving patient management.
This kit plays a vital role in differentiating true TB infections from NTM-related pulmonary or extrapulmonary diseases — a growing global challenge in tuberculosis-endemic regions.
| Targets Covered | |
|---|---|
| mpt64 gene: Specific to Mycobacterium tuberculosis (MTB). | |
| KU gene: Specific to Non-Tuberculous Mycobacteria (NTM). | |
| Detects clinically significant NTM species, including: M. avium, M. abscessus, M. fortuitum, M. kansasii. | |
Diagnostic Laboratories:- Efficiently manage suspected TB/NTM cases
Hospitals & Clinics:- Guide appropriate treatment decisions
Public Health Programs:- Track and respond to emerging NTM prevalence
Example report highlights MTB-positive, NTM-positive, or negative results, along with amplification curves for each target and internal control validation.
| Commercial Name | Cat No. | Pack Size | Compatible Instruments |
|---|---|---|---|
| MTB-NTM Multiplex Real Time PCR Kit | G2M707421R | 24T | OnePCR-Rapi-Q Ultra-Fast System |
| MTB-NTM Multiplex Real Time PCR Kit | G2M707421R | 48T | Rapi-Q POC Device |
Advanced, reliable, and clinically validated differential diagnosis technology.
CE-IVD certified; validated on NABL & ICMR-approved PCR systems for global diagnostic compliance.
Used by clinical laboratories and TB research centers globally to accurately identify MTB and NTM infections.
Delivers robust amplification and precise detection, even in complex or low-DNA samples.
Supports clinicians in selecting the right therapy, minimizing treatment delays and improving outcomes.
Download useful documents and technical information for the MTB-NTM Multiplex Kit.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.
© 2025 Genes2me. All rights reserved.